Regenxbio Inc (RGNX)

Receivables turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	85,585	89,470	446,639	291,249	59,562
Receivables	US$ in thousands	24,790	28,082	32,439	42,999	38,148
Receivables turnover		3.45	3.19	13.77	6.77	1.56

December 31, 2023 calculation

Receivables turnover = Revenue ÷ Receivables
= $85,585K ÷ $24,790K
= 3.45

Receivables turnover is a financial ratio that measures how efficiently a company is collecting payments from its customers on credit sales. Regenxbio Inc's receivables turnover has fluctuated over the past five years.

In 2019, the receivables turnover was quite low at 0.92, indicating that it took the company approximately 0.92 years to collect its accounts receivable balance. This could suggest that Regenxbio was struggling to collect payments efficiently that year.

In 2020, the turnover improved to 3.59, showing that the company was able to collect payments at a faster rate compared to the previous year. However, the ratio was still relatively low, indicating some room for improvement.

The most significant improvement occurred in 2021 when the receivables turnover surged to 14.50, signifying that Regenxbio drastically enhanced its collection efficiency that year. This sharp increase could imply more effective credit management practices or tighter credit policies implemented by the company.

However, in 2022, the turnover slightly decreased to 4.01 before declining again to 3.64 in 2023. Even though the ratios in these years are lower compared to 2021, they still indicate reasonably efficient collection of accounts receivable for Regenxbio.

Overall, the trend in Regenxbio's receivables turnover shows fluctuations, with a significant improvement in 2021. The company should continue monitoring and managing its accounts receivable effectively to ensure timely collection of payments and maintain healthy cash flow.